AbbVie today announced that the European Commission (EC) granted marketing authorization to RINVOQ® for the treatment of giant cell arteritis (GCA)

ProRx Pharma, the health and wellness 503B outsourcing facility, today announced the launch of four new injectables in its health and wellness product line

ABL Bio Inc. a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative diseases

George Clinical, a leading clinical research organization (CRO) operating worldwide, is pleased to announce it has rebranded to become Emerald Clinical Trials.

Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval for Vanrafia® (atrasentan), a potent and selective endothelin

ERBC, a leading preclinical contract research organization (CRO), and Menarini Biotech, a Menarini Group company, offering services as a custom development

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform

Fluor Corporation announced today that it has received a letter of intent from one of the world’s leading pharmaceutical makers to provide engineering

SHL Medical, a world-leading solutions provider of advanced drug delivery systems, and Kindeva Drug Delivery, a global CDMO and drug delivery expert

Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)